Impact of Extracellular Vesicle Isolation Methods on Downstream miRNA Analysis in Semen: A Comparative Study
Autor: | Lluís Bassas, Manel Castells, F. Vigués, Olga López-Rodrigo, Alexandre de la Fuente, Carolina Herrero, Marina Mercadal, Sara Larriba |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Male
0301 basic medicine diagnosis extracellular vesicle isolation methods lcsh:Chemistry Prostate cancer 0302 clinical medicine Vesícules seminals lcsh:QH301-705.5 Spectroscopy Seminal vesicles Biochemical markers semen General Medicine Extracellular vesicle Middle Aged prostate cancer Computer Science Applications Prostate-specific antigen Biochemistry 030220 oncology & carcinogenesis Marcadors bioquímics Biomarker (medicine) biomarker extracellular vesicles microvesicles Adult Semen exosomes Biology Cell Fractionation Exosome Catalysis Article Inorganic Chemistry 03 medical and health sciences microRNA Biomarkers Tumor medicine Humans Physical and Theoretical Chemistry Molecular Biology Aged Càncer de pròstata Organic Chemistry Liquid Biopsy Prostatic Neoplasms medicine.disease Microvesicles MicroRNAs 030104 developmental biology lcsh:Biology (General) lcsh:QD1-999 extracellular vesicle miRNA analysis |
Zdroj: | International Journal of Molecular Sciences Dipòsit Digital de la UB Universidad de Barcelona Volume 21 Issue 17 International Journal of Molecular Sciences, Vol 21, Iss 5949, p 5949 (2020) |
ISSN: | 1422-0067 |
Popis: | Seminal plasma (SP) contains a unique concentration of miRNA, mostly contained in small extracellular vesicles (sEVs) such as exosomes, some of which could be clinically useful for diagnosis and/or prognosis of urogenital diseases such as prostate cancer (PCa). We optimized several exosome-EV isolation technologies for their use in semen, evaluating EV purifying effectiveness and impact on the downstream analysis of miRNAs against results from the standard ultracentrifugation (UC) method to implement the use of SP sEV_miRNAs as noninvasive biomarkers for PCa. Our results evidenced that commercial kits designed to isolate exosomes/EVs from blood or urine are mostly applicable to SP, but showed quantitative and qualitative variability between them. ExoGAG 3500× g and the miRCURY Cell/Urine/CSF 1500× g methods resulted as equivalent alternative procedures to UC for isolating exosomes/sEVs from semen for nanoparticle characteristics and quality of RNA contained in vesicles. Additionally, the expression profile of the altered semen sEV-miRNAs in PCa varies depending on the EV isolation method applied. This is possibly due to different extraction techniques yielding different proportions of sEV subtypes. This is evidence that the exosome-EV isolation method has a significant impact on the analysis of the miRNAs contained within, with important consequences for their use as clinical biomarkers. Therefore, miRNA analysis results for EVs cannot be directly extrapolated between different EV isolation methods until clear markers for delineation between microvesicles and exosomes are established. However, EV extraction methodology affects combined models (semen exosome miRNA signatures plus blood Prostate specific antigen (PSA) concentration for PCa diagnosis) less specifically our previously described (miR-142-3p + miR-142-5p + miR-223-3p + PSA) model functions as molecular marker from EVs from any of the three isolation methods, potentially improving the efficiency of PSA PCa diagnosis. |
Databáze: | OpenAIRE |
Externí odkaz: |